Biogen and Apple have announced that they will collaborate on a new virtual research study investigating the role of smart devices could have on monitoring cognitive health.
The multi-year, observational study will evaluate the role that Apple Watch and iPhone could play in monitoring cognitive performance and screening for decline in cognitive health, including mild cognitive impairment.
The study will launch later in 2021 and is set to enrol participants including young and ageing adults with a range of cognitive performance.
Its primary objectives are to develop digital biomarkers to help monitor cognitive performance over time and to identify the early signs of mild cognitive impairment.
Read more: http://www.pharmatimes.com/news/biogen_and_apple_partner_on_cognitive_health_study_1361112